Horizon Pharma (HZNP), Mallinckrodt Enter Co-Promotion Agreement w/ Covidien (COV) for DUEXIS

June 18, 2012 6:34 AM EDT Send to a Friend
Horizon Pharma, Inc. (Nasdaq: HZNP) and Mallinckrodt LLC the Pharmaceuticals business of Covidien (NYSE: COV), announced today that they have ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login